Georgios Chrysos
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in ⓘ
-
- Antibiotic Use and Resistance 4
- Virology 6
- HIV Research and Treatment 6
- Co-authors
- Olympia Zarkotou (4 shared papers)Athanasios Tsakris (3 shared papers)Spyros Pournaras (3 shared papers)Katerina Themeli-Digalaki (2 shared papers)Athanassios Prekates (1 shared paper)Evangelia Voulgari (1 shared paper)Helen Sambatakou (8 shared papers)Anastasia Antoniadou (7 shared papers)
- Journals
- AIDS (2 papers)Viruses (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)PLoS ONE (2 papers)Scientific Reports (1 paper)
- Partner nations
- GreeceUnited StatesBelgium
In The Last Decade
Georgios Chrysos
14 papers receiving 236 citations
Peers
Comparison fields: 5 of 47
- Applied Microbiology and Biotechnology 52
- Molecular Medicine 99
- Virology 81
- Infectious Diseases 105
- Endocrinology 23
Countries citing papers authored by Georgios Chrysos
This map shows the geographic impact of Georgios Chrysos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgios Chrysos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgios Chrysos more than expected).
Fields of papers citing papers by Georgios Chrysos
This network shows the impact of papers produced by Georgios Chrysos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgios Chrysos. The network helps show where Georgios Chrysos may publish in the future.
Co-authors
The 25 scholars most cited alongside Georgios Chrysos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 87 | |
| 2 | 2007 | 54 | |
| 3 | 2022 | 17 | |
| 4 | 2019 | 16 | |
| 5 | 2018 | 12 | |
| 6 | 2001 | 12 | |
| 7 | 2021 | 9 | |
| 8 | 2022 | 8 | |
| 9 | 2017 | 7 | |
| 10 | 2021 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 4 | |
| 13 | 2025 | 2 | |
| 14 | Development of effective hospital-based antibiotic stewardship program. The role of infectious disease specialist | 2017 | 1 |
| 15 | 2025 | 1 | |
| 16 | 2024 | 0 | |
| 17 | 2024 | 0 |
About Georgios Chrysos
Georgios Chrysos is a scholar working on Applied Microbiology and Biotechnology, Virology, Critical Care and Intensive Care Medicine, Infectious Diseases and Clinical Biochemistry, having authored 17 papers that have together received 241 indexed citations. Recurring topics across this work include HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (6 papers), HIV, Drug Use, Sexual Risk (4 papers), HIV/AIDS drug development and treatment (4 papers), Antibiotic Use and Resistance (4 papers), Nosocomial Infections in ICU (3 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (52 citations), Molecular Medicine (99 citations), Virology (81 citations), Infectious Diseases (105 citations) and Endocrinology (23 citations). Georgios Chrysos has collaborated with scholars based in Greece, United States and Belgium. Frequent co-authors include Olympia Zarkotou, Athanasios Tsakris, Spyros Pournaras, Katerina Themeli-Digalaki, Athanassios Prekates, Evangelia Voulgari, Helen Sambatakou, Anastasia Antoniadou, Dimitrios Paraskevis and Gkikas Magiorkinis. Their work appears in journals such as AIDS, Viruses, European Journal of Clinical Microbiology & Infectious Diseases, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.